Hjem › Idiopatisk pulmonal fibrose › Texas
Kliniske studier for Idiopatisk pulmonal fibrose i Texas
11 studier for Idiopatisk pulmonal fibrose søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- El Paso Pulmonary Association, P.A., El Paso
- Baylor College of Medicine, Houston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Houston
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07652658A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Premier Pulmonary Critical Care and Sleep Medicine, PA, Denison
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07516951RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Horizon Clinical Research Group, Cypress
- El Paso Pulmonary Association, PA, El Paso
- Elevate Clinical Research, Houston
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Baylor University Medical Center, Dallas
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- og 2 flere
RekruttererObservasjonsstudie
Alder 21 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Dallas, TX, Dallas
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT05975983Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.